论文部分内容阅读
目的探索血糖变异性与大面积脑梗死患者预后的关系。方法选取2013年7月至2015年12月于我院神经内科重症监护室(NICU)治疗的大面积脑梗死患者111例,分为存活组88例和3个月死亡组23例,分析两组血糖情况,对平均血糖(GluAve)、血糖标准差(GluSD)、血糖变异系数(GluCV)、最大血糖波动幅度(LAGE)进行计算,分析血糖变异性与患者死亡的关系。结果死亡组GluSD、GluCV和LAGE均高于存活组[(4.75±0.46)vs(1.89±0.70)mmol/L,(53.66±4.82)vs(26.06±4。82)mmol/L,(19.03±3.51)vs(6.75±1.21)mmol/L,P<0.01],死亡组GluAve与存活组比较,差异无统计学意义(P>0.05)。结论血糖变异性与大面积脑梗死患者的死亡密切相关,比GluAv水平能更好的预测患者预后。
Objective To explore the relationship between blood glucose variability and the prognosis of patients with large area cerebral infarction. Methods A total of 111 patients with large-area cerebral infarction who were treated in Department of Neurology Intensive Care Unit (NICU) from July 2013 to December 2015 were divided into survivors group (88 cases) and death cases group (3 months). Two groups Blood glucose, GluAve, GluSD, GluCV and LAGE were calculated to analyze the relationship between the blood glucose variability and the patient’s death. Results GluSD, GluCV and LAGE in death group were significantly higher than those in survival group [(4.75 ± 0.46) vs (1.89 ± 0.70) mmol / L, (53.66 ± 4.82) vs (26.06 ± 4.82) mmol / L, ) vs (6.75 ± 1.21) mmol / L, P <0.01]. There was no significant difference in GluAve between death group and survival group (P> 0.05). Conclusion The blood glucose variability is closely related to the death of patients with large area cerebral infarction, which can predict the prognosis better than GluAv level.